Denali Therapeutics Inc (DNLI) News

Emerald to Participate in Maxim Group TMT Conference

Emerald Holding, Inc. (NYSE: EEX) (“Emerald” or the “Company”), America’s largest producer of trade shows and their associated conferences...

Form 8-K - Current report

Form 3 - Initial statement of beneficial ownership of securities

Emerald to Participate in Goldman Sachs’ Ninth Annual Leveraged Finance and Credit Conference

Emerald Holding, Inc. (NYSE: EEX) (“Emerald” or the “Company”), America’s largest producer of trade shows and their associated conferences...

Emerald Reports First Quarter 2024 Financial Results

Revenue Growth of 9.1% Year-over-Year Reaffirms FY 2024 Guidance Emerald Holding, Inc. (NYSE: EEX) (“Emerald” or the “Company”), America’s...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Emerald Announces Date for First Quarter 2024 Financial Results Conference Call

Emerald Holding, Inc. (NYSE: EEX) (“Emerald” or the “Company”), today announced that it will release its financial results for the first quarter...

Emerald Holding, Inc. Announces Mandatory Conversion Date for Series A Convertible Participating Preferred Stock

Emerald Holding, Inc. (NYSE: EEX) (“Emerald”) announced today that it has delivered a notice of mandatory conversion to the holders of its Series...

Emerald to Participate in the 36th Annual Roth Conference

Emerald Holding, Inc. (NYSE: EEX) (“Emerald” or the “Company”), today announced that David Doft, the Company’s Chief Financial Officer, is...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Emerald Reports Fourth Quarter and Full Year 2023 Financial Results

Revenue Growth of 17.5% Year-over-Year Emerald Holding, Inc. (NYSE: EEX) (“Emerald” or the “Company”), America’s largest producer of trade shows...